Protocol Used: 0.25 mg BPC-157 subcutaneous injection daily for 6 weeks, administered 2 inches proximal to Achilles insertion point, combined with eccentric heel drops and gradual return to running
531,532,533,534 Although there is no substantial treatment-specific improvement in core social symptoms, recent findings on the long-term beneficial effects on repeated behaviours and feelings of avoidance are encouraging and suggest that OT may have therapeutic promise in the treatment of ASD
If you increase your dose to get results, you are also increasing your exposure to potentially impure substances
Proper tier matching ensures safety and optimal outcomes
When dermal papilla cells die or become dysfunctional, the follicle miniaturizes
The brief fasting period enhances Sermorelins effects without requiring extended fasting protocols